CN105833016A - Traditional Chinese medicine composition for treating ovarian cancer - Google Patents

Traditional Chinese medicine composition for treating ovarian cancer Download PDF

Info

Publication number
CN105833016A
CN105833016A CN201610365040.5A CN201610365040A CN105833016A CN 105833016 A CN105833016 A CN 105833016A CN 201610365040 A CN201610365040 A CN 201610365040A CN 105833016 A CN105833016 A CN 105833016A
Authority
CN
China
Prior art keywords
parts
radix
fructus
herba
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610365040.5A
Other languages
Chinese (zh)
Inventor
宋羽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610365040.5A priority Critical patent/CN105833016A/en
Publication of CN105833016A publication Critical patent/CN105833016A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254Acanthopanax or Eleutherococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285Aucklandia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/30Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/328Commiphora, e.g. mecca myrrh or balm of Gilead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/39Convolvulaceae (Morning-glory family), e.g. bindweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/41Crassulaceae (Stonecrop family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969Polygonatum (Solomon's seal)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/90Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating ovarian cancer. The traditional Chinese medicine composition is prepared by, by weight, 0.3-0.9 part of radix acanthopanacis senticosi, 3.6-5.8 parts of brucea javanica, 0.6-2.8 parts of radix ginseng rubra, 5.0-8.3 parts of radix astragali, 2.1-3.5 parts of myrrh, 6.3-9.0 parts of radix lithospermi, 0.5-2.8 parts of ganoderma lucidum, 0.4-3 parts of panax notoginseng, 2.1-5.6 parts of ramulus cinnamomi, 0.2-2.3 parts of agrimonia pilosa ledeb, 40-50 parts of Smilax nipponica Miq., 15-25 parts of Veronica peregrina L., 10-20 parts of Schisandra glaucescens Diels., 5-8 parts of semen cuscutae, 9-13 parts of folium ginkgo and 3.0-9.6 parts of Scrophulariaceae Striga masuria. The traditional Chinese medicine composition has beneficial effects of strengthening the body resistance and consolidating the basis, invigorating qi to nourish the blood, promoting blood circulation to remove blood stasis, clearing away heat and toxic materials and resisting cancer and is evident in effect, quick in action and capable of resisting the ovarian cancer by coordinating with other treatment manners.

Description

A kind of Chinese medicine composition treating ovarian cancer
Technical field
The invention belongs to treat the field of Chinese medicines of tumor.
Background technology
Malignant tumor of ovary is one of common malignant tumor of female sex organ, and sickness rate is only second to cervical cancer With carcinoma of uterine body and arrange residence the 3rd.But ovarian epithelium mortality of carcinoma accounts for the first place of all kinds of gynecological tumor, to woman Schoolgirl's life causes serious threat.Now it is intended to treat the Chinese medicine aspect of ovarian tumor, there are some the most not Foot: one is that therapeutic effect is the most obvious;Two is that the comparison that takes effect is slow.To such an extent as to many ovarian cancer patients or Recurring after can not effectively suppressing tumor growth, or excision, patient and family members thereof are not satisfied to this.
For posed problems above, the present invention provides a kind of Chinese medicine treating ovarian cancer, and it can solve the problem that in the past In treatment of ovarian cancer, effect is obvious not, and the problem that the comparison that takes effect is slow is effective, instant effect, has effect Significantly, the advantage of quick result.
Summary of the invention
Present invention aim to address the problem proposed in background technology.
In order to reach object above, the technical solution used in the present invention is as follows:
A kind of Chinese medicine composition treating ovarian cancer, is characterized in that: it is to make with the component of following weight ratio , its component proportioning is:
Radix Et Caulis Acanthopanacis Senticosi 0.3-0.9 part, Fructus Bruceae 3.6-5.8 part, Radix Ginseng Rubra 0.6-2.8 part, Radix Astragali 5.0-8.3 Part, Myrrha 2.1-3.5 part, Radix Arnebiae (Radix Lithospermi) 6.3-9.0 part, Ganoderma 0.5-2.8 part, Radix Notoginseng 0.4-3 part, Ramulus Cinnamomi 2.1-5.6 part, Herba Agrimoniae 0.2-2.3 part, Rhizoma Smilacis nipponicae 40-50 part, Herba Veronicae peregrinae 15-25 part, flower blood Rattan 10-20 part, Semen Cuscutae 5-8 part, Folium Ginkgo 9-13 part;Big Herba Lobeliae Chinensis 3.0-9.6 part, Fructus Broussonetiae 30-40 Part, fruit 10-16 part, Herba Silybi mariani fly Ji 0.8-7.6 part, Rhizoma Polygonati Cirrhifolii 17-35 part, Cornu Cervi Degelatinatum 4-15 Part, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 2-9 part, Radix Rhodiolae Yunnanensis 5-15 part, Herba Sedi 25-30 part, grand calyx angelica root 10-20 part, Rhizoma Atractylodis Macrocephalae 4-15 part, Fructus Akebiae 3.2-6.8 part, Radix Aucklandiae 5.6-12 part, Radix Rehmanniae 9-12 part, Fructus Arctii 10-19 Part, Fructus Forsythiae 15-33 part.
The present invention compared with prior art, provides the benefit that: can solve the problem that effect during conventional treatment of ovarian cancer Obvious not, the problem that the comparison that takes effect is slow, it is accordingly required in particular to it is noted that through practical proof many times, Only when Radix Et Caulis Acanthopanacis Senticosi, Fructus Bruceae, the proportioning of Schisandra glaucescens Diels. are 0.3-0.9:3.6-5.8:10-20 when, association Best with synergistic effect, the Chinese medicine composition of this treatment ovarian cancer is notable to treatment ovarian cancer effect, takes effect relatively Hurry up.
Detailed description of the invention
The following is the specific embodiment of the present invention, technical scheme is described further, but Embodiments of the present invention are not limited to these embodiments.
Embodiment 1, take formula as below (by weight):
Radix Et Caulis Acanthopanacis Senticosi 0.6 part, Fructus Bruceae 4.3 parts, Radix Ginseng Rubra 2.0 parts, the Radix Astragali 6.3 parts, Myrrha 2.8 Part, Radix Arnebiae (Radix Lithospermi) 7.5 parts, Ganoderma 1.5 parts, Radix Notoginseng 2 parts, Ramulus Cinnamomi 2.9 parts, Herba Agrimoniae 1.8 parts, Rhizoma Smilacis nipponicae 45 parts, Herba Veronicae peregrinae 20 parts, Schisandra glaucescens Diels. 15 parts, Semen Cuscutae 6 parts, Folium Ginkgo 10 parts, big Herba Lobeliae Chinensis 5.8 parts, Fructus Broussonetiae 33 parts, fruit 12 parts, Herba Silybi mariani 4.9 parts, old Tiger Rhizoma Zingiberis Recens 22 parts, Cornu Cervi Degelatinatum 12 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 7.5 parts, Radix Rhodiolae Yunnanensis 11 parts, Herba Sedi 26 parts, grand Calyx angelica root 18 parts, the Rhizoma Atractylodis Macrocephalae 9 parts, Fructus Akebiae 5.0 parts, the Radix Aucklandiae 8 parts, 10 parts of the Radix Rehmanniae, Fructus Arctii 17 parts, Fructus Forsythiae 22 parts.
(1) by above-mentioned weight ratio, Radix Et Caulis Acanthopanacis Senticosi, Fructus Bruceae, Ganoderma, Radix Notoginseng, Ramulus Cinnamomi, Herba Agrimoniae part, horse hair are stretched Muscle, Herba Veronicae peregrinae, Schisandra glaucescens Diels., Fructus Broussonetiae, fruit, Herba Silybi mariani, Rhizoma Polygonati Cirrhifolii, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw., Radix Rhodiolae Yunnanensis, Herba Sedi, Fructus Akebiae, the Radix Aucklandiae, clean roguing, dry, be ground into granule;
(2) take above-mentioned granule and add 3-8 times amount 42%-75% alcohol reflux 2-5 time, 1.0-2.5h/ time, Alcohol extract;
(3) by above-mentioned weight ratio, by Radix Ginseng Rubra, the Radix Astragali, Myrrha, Radix Arnebiae (Radix Lithospermi), Semen Cuscutae, Folium Ginkgo, big Herba Lobeliae Chinensis, Cornu Cervi Degelatinatum, grand calyx angelica root, the Rhizoma Atractylodis Macrocephalae, the Radix Rehmanniae, Fructus Arctii, Fructus Forsythiae are ground into fine powder respectively, with above-mentioned alcohol extract It is sufficiently mixed, stirs, obtain medicine liquid mixture;
(4) above-mentioned medicine liquid mixture is added 1.5-2 times of water, soak 2-2.5h, be placed in multi-functional extraction in filling and decoct 2 times: add up the water of medical material 4-6 times amount for the first time, decocting 2h, take decocting liquid, filter, second time adds up medicine The water of 8-10 times amount, decocts 2.5h, takes twice decocting liquid and merges, filters, and when being concentrated into 90 DEG C, relative density is The concentrated solution of 1.38, sets to 0 concentrated solution-5 DEG C of deepfreeze 48h, obtains semi-finished product;
(5) again by the 4th step obtain described semi-finished product carry out successively filtration treatment, concentration, embedding process, Sterilization treatment, obtains every milliliter of Chinese medicine composition oral liquid finished product containing 2.5g crude drug amount.
Embodiment 2, take formula as below (by weight):
Radix Et Caulis Acanthopanacis Senticosi 0.4 part, Fructus Bruceae 3.8 parts, Radix Ginseng Rubra 1.0 parts, the Radix Astragali 5.3 parts, Myrrha 2.8 parts, Radix Arnebiae (Radix Lithospermi) 6.5 parts, Ganoderma 0.8 part, Radix Notoginseng 0.5 part, Ramulus Cinnamomi 2.3 parts, Herba Agrimoniae 0.5 part, horse Tail stretch 41 parts of muscle, Herba Veronicae peregrinae 16 parts, Schisandra glaucescens Diels. 11 parts, Semen Cuscutae 5.5 parts, Folium Ginkgo 10 parts, Big Herba Lobeliae Chinensis 3.3 parts, Fructus Broussonetiae 32 parts, fruit 12 parts, Herba Silybi mariani 0.9 part, Rhizoma Polygonati Cirrhifolii 18 Part, Cornu Cervi Degelatinatum 6 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 2.5 parts, Radix Rhodiolae Yunnanensis 6.3 parts, Herba Sedi 26 parts, grand calyx Radix Angelicae Sinensis Root 13 parts, the Rhizoma Atractylodis Macrocephalae 6 parts, Fructus Akebiae 3.6 parts, the Radix Aucklandiae 5.8 parts, 10.5 parts of the Radix Rehmanniae, Fructus Arctii 12 Part, Fructus Forsythiae 17 parts.
By above-mentioned same method, make every milliliter of crude drug amount Chinese medicine composition oral liquid Han 2.5g.
Embodiment 3, take formula as below (by weight):
Radix Et Caulis Acanthopanacis Senticosi 0.8 part, Fructus Bruceae 5.6 parts, Radix Ginseng Rubra 2.5 parts, the Radix Astragali 8.1 parts, Myrrha 3.3 Part, Radix Arnebiae (Radix Lithospermi) 8 parts, Ganoderma 2.5 parts, Radix Notoginseng 2.8 parts, Ramulus Cinnamomi 5.3 parts, Herba Agrimoniae 2.2 parts, Rhizoma Smilacis nipponicae 49 parts, Herba Veronicae peregrinae 24 parts, Schisandra glaucescens Diels. 19 parts, Semen Cuscutae 7 parts, Folium Ginkgo 12 parts, Big Herba Lobeliae Chinensis 9.3 parts, Fructus Broussonetiae 38.5 parts, fruit 10-16 part, Herba Silybi mariani 7.3 parts, tiger Rhizoma Zingiberis Recens 32 parts, Cornu Cervi Degelatinatum 13 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 8 parts, Radix Rhodiolae Yunnanensis 14 parts, Herba Sedi 25-30 part, grand Calyx angelica root 19 parts, the Rhizoma Atractylodis Macrocephalae 13.8 parts, Fructus Akebiae 6.3 parts, the Radix Aucklandiae 11.3 parts, 10.9 parts of the Radix Rehmanniae, Fructus Arctii 18 parts, Fructus Forsythiae 31.8 parts.
By above-mentioned same method, make every milliliter of crude drug amount Chinese medicine composition oral liquid Han 2.5g.
Embodiment 4:
Take formula as below (by weight):
Radix Et Caulis Acanthopanacis Senticosi 1.2 parts, Fructus Bruceae 2.6 parts, Radix Ginseng Rubra 2.5 parts, the Radix Astragali 8.1 parts, Myrrha 3.3 Part, Radix Arnebiae (Radix Lithospermi) 8 parts, Ganoderma 2.5 parts, Radix Notoginseng 2.8 parts, Ramulus Cinnamomi 5.3 parts, Herba Agrimoniae 2.2 parts, Rhizoma Smilacis nipponicae 49 parts, Herba Veronicae peregrinae 24 parts, Schisandra glaucescens Diels. 8 parts, Semen Cuscutae 7 parts, Folium Ginkgo 12 parts, Big Herba Lobeliae Chinensis 9.3 parts, Fructus Broussonetiae 38.5 parts, fruit 10-16 part, Herba Silybi mariani 7.3 parts, tiger Rhizoma Zingiberis Recens 32 parts, Cornu Cervi Degelatinatum 13 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 8 parts, Radix Rhodiolae Yunnanensis 14 parts, Herba Sedi 25-30 part, grand Calyx angelica root 19 parts, the Rhizoma Atractylodis Macrocephalae 13.8 parts, Fructus Akebiae 6.3 parts, the Radix Aucklandiae 11.3 parts, 10.9 parts of the Radix Rehmanniae, Fructus Arctii 18 parts, Fructus Forsythiae 31.8 parts.
Illustrate: Radix Et Caulis Acanthopanacis Senticosi, Fructus Bruceae, Schisandra glaucescens Diels. proportioning not within the scope of described in claims.
Embodiment 5:
Take formula as below (by weight):
Radix Et Caulis Acanthopanacis Senticosi 0.1 part, Fructus Bruceae 8 parts, Radix Ginseng Rubra 2.5 parts, the Radix Astragali 8.1 parts, Myrrha 3.3 parts, Radix Arnebiae (Radix Lithospermi) 8 parts, Ganoderma 2.5 parts, Radix Notoginseng 2.8 parts, Ramulus Cinnamomi 5.3 parts, Herba Agrimoniae 2.2 parts, horse Tail stretches 49 parts of muscle, Herba Veronicae peregrinae 24 parts, Schisandra glaucescens Diels. 3 parts, Semen Cuscutae 7 parts, Folium Ginkgo 12 parts, big Herba Lobeliae Chinensis 9.3 parts, Fructus Broussonetiae 38.5 parts, fruit 10-16 part, Herba Silybi mariani 7.3 parts, Rhizoma Polygonati Cirrhifolii 32 parts, Cornu Cervi Degelatinatum 13 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 8 parts, Radix Rhodiolae Yunnanensis 14 parts, Herba Sedi 25-30 part, grand calyx Angelica root 19 parts, the Rhizoma Atractylodis Macrocephalae 13.8 parts, Fructus Akebiae 6.3 parts, the Radix Aucklandiae 11.3 parts, 10.9 parts of the Radix Rehmanniae, Fructus Arctii 18 parts, Fructus Forsythiae 31.8 parts.
Illustrate: Radix Et Caulis Acanthopanacis Senticosi, Fructus Bruceae, Schisandra glaucescens Diels. proportioning not within the scope of described in claims.
Clinical data:
The present invention is as a example by traditional Chinese medical science ovarian cancer, through 50 example clinical observations.Select tcm diagnosis ovarian cancer for mark Accurate: limb is soft weak, lower abdominal distention pain, and CT is shown in ovary region tumors.As above symptom, can make a definite diagnosis.? Making a definite diagnosis the object of observation, without other serious disease, the age is 31 years old-62 years old, 52.6 years old mean age. Efficacy determination:
1, effective: body constitution strengthens, limbs are strong, and abdominal discomfort disappears, and ovarian tumor tumor body reduces, other portion Position has no nascent tumor.
2, effective: body constitution strengthens, and ovarian tumor has no increase, and other position has no nascent tumor.
3, invalid: symptom is unchanged, ovarian tumor tumor body increases, or nascent tumor occurs in other position.
During clinical experiment, withdraw other medicines and health nutrient.Take Chinese medicine oral liquid of the present invention, observe 3 Individual month, be a course for the treatment of.Instructions of taking: three times a day, each 10ml, one after each meal, after 1 month Symptom i.e. has alleviation, and after taking 3 months, symptom has clear improvement.
Take the medicinal liquid of embodiment 1 preparation: in 50 people of clinical experiment, effective 20 people, effective 29 people, Invalid 1 people, total effective rate 98.0%.
Take the medicinal liquid of embodiment 2 preparation: in 50 people of clinical experiment, effective 20 people, effective 28 people, Invalid 2 people, total effective rate 96.0%.
Take the medicinal liquid of embodiment 3 preparation: in 50 people of clinical experiment, effective 22 people, effective 27 people, Invalid 1 people, total effective rate 98.0%.
Take the medicinal liquid of embodiment 4 preparation: in 50 people of clinical experiment, effective 2 people, effective 8 people, Invalid 40 people, total effective rate 20.0%.
Take the medicinal liquid of embodiment 5 preparation: in 50 people of clinical experiment, effective 1 people, effective 9 people, Invalid 40 people, total effective rate 20.0%.
Owing to embodiment 4 and embodiment 5 do not install the requirement proportioning preparation of the present invention, experiment effect is very Difference, also illustrate that the medicine of the present invention is only when Radix Et Caulis Acanthopanacis Senticosi, Fructus Bruceae, the joining of Schisandra glaucescens Diels. to a certain extent Than for the when of 0.3-0.9:3.6-5.8:10-20, cooperative synergism effect is just most preferably over the course for the treatment of.

Claims (1)

1. treat a Chinese medicine composition for ovarian cancer, it is characterized in that: it is to make with the component of following weight ratio , its component proportioning is:
Radix Et Caulis Acanthopanacis Senticosi 0.3-0.9 part, Fructus Bruceae 3.6-5.8 part, Radix Ginseng Rubra 0.6-2.8 part, Radix Astragali 5.0-8.3 Part, Myrrha 2.1-3.5 part, Radix Arnebiae (Radix Lithospermi) 6.3-9.0 part, Ganoderma 0.5-2.8 part, Radix Notoginseng 0.4-3 part, Ramulus Cinnamomi 2.1-5.6 part, Herba Agrimoniae 0.2-2.3 part, Rhizoma Smilacis nipponicae 40-50 part, Herba Veronicae peregrinae 15-25 part, flower blood Rattan 10-20 part, Semen Cuscutae 5-8 part, Folium Ginkgo 9-13 part;Big Herba Lobeliae Chinensis 3.0-9.6 part, Fructus Broussonetiae 30-40 Part, fruit 10-16 part, Herba Silybi mariani 0.8-7.6 part, Rhizoma Polygonati Cirrhifolii 17-35 part, Cornu Cervi Degelatinatum 4-15 part, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 2-9 part, Radix Rhodiolae Yunnanensis 5-15 part, Herba Sedi 25-30 part, grand calyx angelica root 10-20 part, the Rhizoma Atractylodis Macrocephalae 4-15 part, Fructus Akebiae 3.2-6.8 part, Radix Aucklandiae 5.6-12 part, Radix Rehmanniae 9-12 part, Fructus Arctii 10-19 part, Fructus Forsythiae Fructus Forsythiae 15-33 part.
CN201610365040.5A 2016-05-26 2016-05-26 Traditional Chinese medicine composition for treating ovarian cancer Pending CN105833016A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610365040.5A CN105833016A (en) 2016-05-26 2016-05-26 Traditional Chinese medicine composition for treating ovarian cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610365040.5A CN105833016A (en) 2016-05-26 2016-05-26 Traditional Chinese medicine composition for treating ovarian cancer

Publications (1)

Publication Number Publication Date
CN105833016A true CN105833016A (en) 2016-08-10

Family

ID=56594710

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610365040.5A Pending CN105833016A (en) 2016-05-26 2016-05-26 Traditional Chinese medicine composition for treating ovarian cancer

Country Status (1)

Country Link
CN (1) CN105833016A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106267029A (en) * 2016-10-12 2017-01-04 南宁多灵生物科技有限公司 A kind of Chinese medicine composition treating ovarian cancer

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1361697A (en) * 1999-08-12 2002-07-31 研究及应用科学协会股份有限公司 Use of ginkgo extract
CN102198226A (en) * 2011-06-09 2011-09-28 彭道生 Chinese herbal medicine composition for treating cancer
CN102335374A (en) * 2011-10-09 2012-02-01 许俊斋 Medicine special for treating lung cancer
CN102423369A (en) * 2011-12-29 2012-04-25 许从玉 Chinese medicinal composition for preventing or treating ovarian cancer
CN103705897A (en) * 2014-01-03 2014-04-09 陈延玲 Cancer pain-relieving plaster
CN104800565A (en) * 2015-04-14 2015-07-29 王先宝 Traditional Chinese medicine for treating esophagus cancer and preparation method
CN105311468A (en) * 2015-11-16 2016-02-10 张秀贞 Traditional Chinese medicine composition for treating lymph cancer and preparation method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1361697A (en) * 1999-08-12 2002-07-31 研究及应用科学协会股份有限公司 Use of ginkgo extract
CN102198226A (en) * 2011-06-09 2011-09-28 彭道生 Chinese herbal medicine composition for treating cancer
CN102335374A (en) * 2011-10-09 2012-02-01 许俊斋 Medicine special for treating lung cancer
CN102423369A (en) * 2011-12-29 2012-04-25 许从玉 Chinese medicinal composition for preventing or treating ovarian cancer
CN103705897A (en) * 2014-01-03 2014-04-09 陈延玲 Cancer pain-relieving plaster
CN104800565A (en) * 2015-04-14 2015-07-29 王先宝 Traditional Chinese medicine for treating esophagus cancer and preparation method
CN105311468A (en) * 2015-11-16 2016-02-10 张秀贞 Traditional Chinese medicine composition for treating lymph cancer and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106267029A (en) * 2016-10-12 2017-01-04 南宁多灵生物科技有限公司 A kind of Chinese medicine composition treating ovarian cancer

Similar Documents

Publication Publication Date Title
CN103071128B (en) Externally-applied plaster for curing dysmenorrhea
CN105477183A (en) Health care wine and preparing method thereof
CN101537146B (en) Chinese medicine for treating carcinoma of colon
CN104173565B (en) A kind of Chinese medicine composition treating menoxenia
CN101530508B (en) Traditional Chinese medicine for treating ovarian cancer
CN101390993B (en) Traditional Chinese medicine for treating diabetic foot
CN104984296A (en) Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof
CN1246031C (en) Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation
CN105833016A (en) Traditional Chinese medicine composition for treating ovarian cancer
CN101518611B (en) Traditional Chinese medicine for treating bone tumor
CN101530490B (en) Traditional Chinese medicine for treating bladder cancer
CN1263479C (en) Chinese traditional medicine for treating cardiopathy
CN101554426B (en) Traditional Chinese medicine for treating diabetic obstipation
CN101985027A (en) Chinese herbal medicine for treating liver cirrhosis
CN101537125B (en) Chinese medicine for treating uterine cancer
CN101537061B (en) Chinese medicine for treating liver cancer
CN100502938C (en) Chinese medicine for gynecological infertility
CN101513516B (en) Drug for treating annexitis
CN101390985B (en) Traditional Chinese medicine for treating diabetes acral necrosis
CN106266929A (en) A kind of blood circulation promoting and blood stasis dispelling life-prolonging pill and preparation method thereof
CN104225311A (en) Neurasthenia heart and spleen tonifying medicament and preparation method
CN104383211A (en) Traditional Chinese medicine clysis fluid for treating chronic renal insufficiency and yang deficiency-induced cold of diabetic nephropathy
CN104248689A (en) Traditional Chinese medicine for treating female sexual hypoactivity
CN104800703A (en) Traditional Chinese medicine composition for treating irregular menstruation
CN104758702A (en) Liver soothing and bladder relieving agent for treating gallstone and preparation method of agent

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160810

WD01 Invention patent application deemed withdrawn after publication